eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hypercalcemia |
| Comorbidity | C0036202|sarcoidosis |
| Sentences | 9 |
| PubMedID- 24246340 | Objective: to report an uncommon cause of 1,25-dihydroxyvitamin d (1,25[oh]2d)-mediated hypercalcemia associated with splenic sarcoidosis and illustrate the evaluation and potential role of fluorodeoxyglucose (fdg) positron emission tomography (pet)/computed tomography (ct) in such patients. |
| PubMedID- 24663253 | We report two cases of one proposed mechanism of hypercalcaemia in sarcoidosis (mechanism 3). |
| PubMedID- 24753153 | Overproduction of 1alpha-hydroxylase is held responsible for the development of hypercalcemia in sarcoidosis patients. |
| PubMedID- 24157819 | The mechanism of hypercalcaemia in sarcoidosis is well described. |
| PubMedID- 21209801 | Corticosteroids have been the first-line therapy in treating hypercalcemia associated with sarcoidosis because of their effectiveness in rapidly correcting hypercalcemia. |
| PubMedID- 23907968 | sarcoidosis as a cause of unappreciated hypercalcaemia in a patient with end-stage renal disease on peritoneal dialysis. |
| PubMedID- 26029574 | Although the emc and sarcoidosis with associated hypercalcemia may have been coincidental in our case, the fact that both lymphadenopathy and hypercalcemia resolved after resection of the primary tumor suggests a more intimate relationship. |
| PubMedID- 25988038 | sarcoidosis presenting with hypercalcaemia following withdrawal of long-term immunosuppression in renal transplantation. |
| PubMedID- 21873732 | The mechanism of hypercalcaemia in sarcoidosis is poorly understood but is thought to involve parathyroid hormone-independent 1-hydroxylation of 25-hydroxyvitamin d within sarcoid lesions. |
Page: 1